The effect of vitamins E and C on the serum levels of leptin and inflammation factors in type II diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202208025N3

Enrollment

120

Registered

2012-03-14

Start date

2011-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic mellitus 2. Non-insulin-dependent diabetes mellitus

Interventions

GROUP 1: consumption of 1000 mg of vitamin C per day for 4 weeks.

Prevention

GROUP 1: consumption of 1000 mg of vitamin C per day for 4 weeks

Eligibility

Sex/Gender

All

Age

35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who had type 2 diabetes. Exclusion criteria: Patients who had liver diseases; Kidney disease; Hypo- or Hyper- thyroidism; myocard infraction or blood disorders and used to drugs containing estrogen; progesterone; Diuretics; lower blood pressure and vitamin C and E; were excluded from the study .......

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Leptin. Timepoint: Before and one month after the intervention. Method of measurement: by ELIZA method (ng/ml).	—

Secondary

Measure	Time frame
Cholestrol. Timepoint: Before and one month after the intervention. Method of measurement: Autoanalyzer (mg/dl).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Noor Behbahani

Ahwaz Jondishapur University of Medical Sciences

mozhgannoorb@yahoo.com+98 61 1378 2914

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026